PB2955: EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB ANDLENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLYUNTREATED FOLLICULAR LYMPHOMA

Kim Linton; Philip Thompson; Stefano Luminari; Carla Casulo; Poliana Patah; Lingmin Zeng; J. P. Mei; Neha Dixit; Daniela Hoehn; Emmanuel Bachy

doi:10.1002/hem3.104

PB2955: EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB ANDLENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLYUNTREATED FOLLICULAR LYMPHOMA

Kim Linton, Philip Thompson, Stefano Luminari, Carla Casulo, Poliana Patah, Lingmin Zeng, J. P. Mei, Neha Dixit, Daniela Hoehn, Emmanuel Bachy

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	5517-5518
Journal	HemaSphere
Volume	8
Issue number	S1
DOIs	https://doi.org/10.1002/hem3.104
Publication status	Published - 14 Jun 2024
Event	European Hematology Association (EHA) Hybrid Congress 2024 - IFEMA MADRID RECINTO FERIAL (fairgrounds), Madrid, Spain Duration: 13 Jun 2024 → 16 Jun 2024 https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress-4/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hem3.104Licence: CC BY-NC-ND

PB2955Final published version, 35 KB

Cite this

@article{8612c92bd5084714b5129bcdec106382,

title = "PB2955: EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB ANDLENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLYUNTREATED FOLLICULAR LYMPHOMA",

author = "Kim Linton and Philip Thompson and Stefano Luminari and Carla Casulo and Poliana Patah and Lingmin Zeng and Mei, {J. P.} and Neha Dixit and Daniela Hoehn and Emmanuel Bachy",

year = "2024",

month = jun,

day = "14",

doi = "10.1002/hem3.104",

language = "English",

volume = "8",

pages = "5517--5518",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams & Wilkins",

number = "S1",

note = "European Hematology Association (EHA) Hybrid Congress 2024, EHA2024 Hybrid Congress ; Conference date: 13-06-2024 Through 16-06-2024",

url = "https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress-4/",

}

TY - JOUR

T1 - PB2955: EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB ANDLENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLYUNTREATED FOLLICULAR LYMPHOMA

AU - Linton, Kim

AU - Thompson, Philip

AU - Luminari, Stefano

AU - Casulo, Carla

AU - Patah, Poliana

AU - Zeng, Lingmin

AU - Mei, J. P.

AU - Dixit, Neha

AU - Hoehn, Daniela

AU - Bachy, Emmanuel

PY - 2024/6/14

Y1 - 2024/6/14

U2 - 10.1002/hem3.104

DO - 10.1002/hem3.104

M3 - Meeting Abstract

SN - 2572-9241

VL - 8

SP - 5517

EP - 5518

JO - HemaSphere

JF - HemaSphere

IS - S1

T2 - European Hematology Association (EHA) Hybrid Congress 2024

Y2 - 13 June 2024 through 16 June 2024

ER -